Determinants of retinopathy progression in type 1 diabetes mellitus
- PMID: 10403352
- DOI: 10.1016/s0002-9343(99)00165-5
Determinants of retinopathy progression in type 1 diabetes mellitus
Abstract
Purpose: To determine the risk factors for retinopathy progression in type 1 (insulin-dependent) diabetes mellitus in a prospective cohort study.
Subjects and methods: Subjects were 485 participants in the Sorbinil Retinopathy Trial, a randomized trial of aldose reductase inhibition among patients aged 18 to 56 years with type 1 diabetes mellitus (duration of 1 to 15 years) and no or only mild retinopathy. Retinopathy progression, assessed by seven-field stereoscopic fundus photography, was defined as worsening by two or more levels on a standardized grading scale at the end of follow-up (median, 41 months).
Results: The relative risks for retinopathy progression according to successively greater quintiles of total glycosylated hemoglobin level at baseline, after adjusting for age, diabetes duration, sorbinil assignment, and other variables, were 1.0, 2.0, 1.6, 3.7, and 4.4 (P trend <0.0001). Risk increased with greater baseline diastolic blood pressure: 1.0 for <70 mm Hg, 1.2 for 70 to 79 mm Hg, and 1.8 for > or =80 mm Hg (P for trend = 0.04). Diastolic blood pressure was a significant risk factor for progression in participants with mild baseline retinopathy (P for trend <0.02) but not in those without retinopathy at entry. Systolic blood pressure, by comparison, was not associated with progression. Baseline total cholesterol level was a marginally significant predictor of retinopathy progression when examined as a categorical variable (relative risks for increasing quartiles; 1.0, 1.6, 1.8, 1.9; P for trend = 0.03) but not when it was examined as a continuous variable or when hypercholesterolemic patients were compared with those with normal levels. Furthermore, when cholesterol levels were updated in subsequent visits, it was not a significant predictor of progression, and low density lipoprotein (LDL) cholesterol levels did not predict progression no matter how analyzed. Smoking was not associated with progression of retinopathy.
Conclusions: Levels of hyperglycemia and diastolic blood pressure predicted progression of retinopathy in type 1 diabetes mellitus. We found only a suggestion of an association between total cholesterol level (but not of LDL cholesterol level) and progression of retinopathy; resolution of this issue will require additional studies with larger sample sizes and longer follow-up.
Similar articles
-
The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial.Arch Ophthalmol. 1995 Jan;113(1):36-51. doi: 10.1001/archopht.1995.01100010038019. Arch Ophthalmol. 1995. PMID: 7826293 Clinical Trial.
-
Factors influencing the onset and progression of diabetic retinopathy in subjects with insulin-dependent diabetes mellitus.Ophthalmology. 1993 Aug;100(8):1133-9. doi: 10.1016/s0161-6420(13)31517-6. Ophthalmology. 1993. PMID: 8341492
-
A randomized trial of sorbinil, an aldose reductase inhibitor, in diabetic retinopathy. Sorbinil Retinopathy Trial Research Group.Arch Ophthalmol. 1990 Sep;108(9):1234-44. doi: 10.1001/archopht.1990.01070110050024. Arch Ophthalmol. 1990. PMID: 2119168 Clinical Trial.
-
Aldose reductase inhibitors and late complications of diabetes.Drugs. 1986;32 Suppl 2:43-55. doi: 10.2165/00003495-198600322-00010. Drugs. 1986. PMID: 3098544 Review.
-
Diabetic retinopathy.J Ky Med Assoc. 1986 Apr;84(4):155-8. J Ky Med Assoc. 1986. PMID: 2422308 Review. No abstract available.
Cited by
-
The therapeutic effects of angiotensin-converting enzyme inhibitors in severe non-proliferative diabetic retinopathy.Korean J Ophthalmol. 2007 Mar;21(1):28-32. doi: 10.3341/kjo.2007.21.1.28. Korean J Ophthalmol. 2007. PMID: 17460429 Free PMC article.
-
Current and future management of diabetic retinopathy: a personalized evidence-based approach.Diabetes Manag (Lond). 2013 Nov 1;3(6):481-494. doi: 10.2217/dmt.13.50. Diabetes Manag (Lond). 2013. PMID: 24932222 Free PMC article.
-
Columbia University's Informatics for Diabetes Education and Telemedicine (IDEATel) Project: rationale and design.J Am Med Inform Assoc. 2002 Jan-Feb;9(1):49-62. doi: 10.1136/jamia.2002.0090049. J Am Med Inform Assoc. 2002. PMID: 11751803 Free PMC article. Clinical Trial.
-
The Bucherer-Bergs Multicomponent Synthesis of Hydantoins-Excellence in Simplicity.Molecules. 2021 Jun 30;26(13):4024. doi: 10.3390/molecules26134024. Molecules. 2021. PMID: 34209381 Free PMC article. Review.
-
Measurement of retinal function with flash-electroretinography in Chinese patients with hyperlipidemia.Graefes Arch Clin Exp Ophthalmol. 2014 Sep;252(9):1385-92. doi: 10.1007/s00417-014-2726-z. Epub 2014 Jul 17. Graefes Arch Clin Exp Ophthalmol. 2014. PMID: 25030239
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical